リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Activation of STING signaling accelerates skin wound healing」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Activation of STING signaling accelerates skin wound healing

水谷, 有希 岐阜大学

2020.04.15

概要

Background
The process of repair after skin injury is precisely regulated by a variety of mediators such as cytokines and chemokines. Recent reports demonstrated that cytoplasmic DNA-sensor cyclic GMP-AMP synthase (cGAS) activates the stimulator of interferon genes (STING) via production of cyclic GMP-AMP (cGAMP) and subsequently induces inflammatory cytokines, including type I interferon (IFN).

Objective
We examined whether activation of the STING pathway by cGAMP affects the process of skin wound repair.

Methods
The skin wound repair model was established using wild-type (WT) mice. Two full-thickness skin biopsies were taken from the right and left subscapular regions. One site was treated with ointment containing cGAMP, and the other was treated with a control ointment. Changes in wound size over time were calculated using photography.

Results
Treatment with cGAMP significantly accelerated skin wound healing up to day 6. Biochemical analyses showed that topical treatment with cGAMP on wound sites promoted STING signaling pathway and enhanced the expression of IFN-β, CXCL10 and CCL2 in the wound sites treated with cGAMP markedly compared with the control. The scratch assay also revealed that cGAMP treatment accelerated wound closure in mouse embryonic fibroblasts. The acceleration of skin wound repair by cGAMP in WT mouse was impaired by administration of anti-IFNR antibody and anti-CXCR3 antibody respectively.

Conclusion
These results revealed that topical treatment with cGAMP accelerates skin wound healing by inducing type I IFN and CXCL10/CXCR3. Topical administration of cGAMP might contribute to new effective treatments for accelerating skin wound healing.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

[1] B. Behm, P. Babilas, M. Landthaler, S. Schreml, Cytokines, chemokines and growth factors in wound healing, J. Eur. Acad. Dermatol. Venereol. 26 (2012) 812–820.

[2] M. Yamamoto, T. Sato, J. Beren, D. Verthelyi, D.M. Klinman, The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides, Biomaterials 32 (2011) 4238–4242.

[3] H. Ito, A. Kanbe, H. Sakai, M. Seishima, Activation of NLRP3 signalling accelerates skin wound healing, Exp. Dermatol. 27 (2018) 80–86.

[4] J. Gregorio, S. Meller, C. Conrad, A. Di Nardo, B. Homey, A. Lauerma, N. Arai, R.L. Gallo, J. DiGiovanni, M. Gilliet, Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons, J. Exp. Med. 207 (2010) 2921–2930.

[5] P. Decker, H. Singh-Jasuja, S. Haager, I. Kotter, H.-G. Rammensee, Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation, J. Immunol. 174 (2005) 3326–3334.

[6] D.B. Stetson, R. Medzhitov, Recognition of cytosolic DNA activates an IRF3- dependent innate immune response, Immunity 24 (2006) 93–103.

[7] L. Sun, J. Wu, F. Du, X. Chen, Z.J. Chen, Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway, Science (80-) 339 (2013) 786–791.

[8] A. Ablasser, M. Goldeck, T. Cavlar, T. Deimling, G. Witte, I. Röhl, K.P. Hopfner, J. Ludwig, V. Hornung, CGAS produces a 20 -50 -linked cyclic dinucleotide second messenger that activates STING, Nature 498 (2013) 380–384.

[9] P. Gao, M. Ascano, Y. Wu, W. Barchet, B.L. Gaffney, T. Zillinger, A.A. Serganov, Y. Liu, R.A. Jones, G. Hartmann, T. Tuschl, D.J. Patel, Cyclic [G(20 ,50 )pA(30 ,50 )p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase, Cell 153 (2013) 1094–1107.

[10] Y. Tanaka, Z.J. Chen, STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway, Sci. Signal. 5 (2012).

[11] H. Ishikawa, Z. Ma, G.N. Barber, STING regulates intracellular DNA-mediated, type i interferon-dependent innate immunity, Nature 461 (2009) 788–792.

[12] X. Cai, Y.H. Chiu, Z.J. Chen, The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling, Mol. Cell 54 (2014) 289–296.

[13] R.M. Devalaraja, L.B. Nanney, Q. Qian, J. Du, Y. Yu, M.N. Devalaraja, A. Richmond, Delayed wound healing in CXCR2 knockout mice, J. Invest. Dermatol. 115 (2000) 234–244.

[14] C.-M. Lo, Nonmuscle myosin IIB is involved in the guidance of fibroblast migration, Mol. Biol. Cell. 15 (2004) 982–989. 28 Y. Mizutani et al. / Journal of Dermatological Science 97 (2020) 21–29

[15] T. Ohkuri, A. Ghosh, A. Kosaka, J. Zhu, M. Ikeura, M. David, S.C. Watkins, S.N. Sarkar, H. Okada, STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment, J. Immunother. Cancer 2 (2014) 228.

[16] S.M. Reilly, S. Chiang, S.J. Decker, L. Chang, M.J. Larsen, J.R. Rubin, J. Mowers, N. M. White, M. Downes, R. Yu, C. Liddle, R.M. Evans, P. Li, J.M. Olefsky, A.R. Saltiel, An inhibitor of the protein kinases TBK1/IKKe improves obesity- related metabolic dysfunctions, Nat. Med. 19 (2013) 313–321.

[17] E.Y. Lee, Z.H. Lee, Y.W. Song, CXCL10 and autoimmune diseases, Autoimmun. Rev. 8 (2009) 379–383.

[18] C.C. Yates, D. Whaley, P. Kulasekeran, W.W. Hancock, B. Lu, R. Bodnar, J. Newsome, P.A. Hebda, A. Wells, Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor, Am. J. Pathol. 171 (2007) 484–495.

[19] S.A. Eming, P. Martin, M. Tomic-Canic, Wound repair and regeneration: mechanisms, signaling, and translation, Sci. Transl. Med. 6 (2014).

[20] H.J. You, S.K.J. Han, Cell therapy for wound healing, Med. Sci. 29 (2014) (2014) 311–319.

[21] O. Takeuchi, S. Akira, Pattern recognition receptors and inflammation, Cell 140 (2010) 805–820.

[22] D.Agnello,C.S.R.Lankford, J. Bream,A.Morinobu,M.Gadina, J.J. O’Shea,D.M. Frucht, Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights, J. Clin. Immunol. 23 (2003) 147–161.

[23] Y. Weng, S.J. Siciliano, K.E. Waldburger, a Sirotina-Meisher, M.J. Staruch, B.L. Daugherty, S.L. Gould, M.S. Springer, J. a DeMartino, Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors, J. Biol. Chem. 273 (1998) 18288–18291.

[24] F.H. Epstein, A.D. Luster, Chemokines — chemotactic cytokines that mediate inflammation, N. Engl. J. Med. 338 (1998) 436–445.

[25] L. Satish, D. Yager, A. Wells, Glu-Leu-Arg-negative CXC chemokine interferon g inducible protein-9 as a mediator of epidermal-dermal communication during wound repair, J. Invest. Dermatol. 120 (2003) 1110–1117.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る